The main culprit in the cinnamon powder is actually derived from tree bark and contains cellulose, an undigestible fiber capable of producing a strong inflammatory response in lung tissue, leading to long term wheezing and a chroniccough, potentially placing patients at further risk for bouts of pneumonitis or even aspiration pneumonia.
On Friday, the U.S. Food and Drug Administration said it approved Breo Ellipta for long-term use and to control flare-ups in patients with chronic obstructive pulmonary disorder, often called smoker's cough.